Peijia Medical Ltd
HKEX:9996
Intrinsic Value
Peijia Medical Ltd. engages in the manufacture and sale of medical devices. [ Read More ]
The intrinsic value of one Peijia Medical Ltd stock under the Base Case scenario is 4.07 HKD. Compared to the current market price of 3.66 HKD, Peijia Medical Ltd is Undervalued by 10%.
Valuation Backtest
Peijia Medical Ltd
Run backtest to discover the historical profit from buying and selling Peijia Medical Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Peijia Medical Ltd
| Current Assets | 1.4B |
| Cash & Short-Term Investments | 1.1B |
| Receivables | 84.9m |
| Other Current Assets | 222.1m |
| Non-Current Assets | 1.5B |
| Long-Term Investments | 458.2m |
| PP&E | 436.1m |
| Intangibles | 533.9m |
| Other Non-Current Assets | 24.5m |
| Current Liabilities | 158.6m |
| Accounts Payable | 155.8m |
| Other Current Liabilities | 2.8m |
| Non-Current Liabilities | 225.6m |
| Long-Term Debt | 185m |
| Other Non-Current Liabilities | 40.6m |
Earnings Waterfall
Peijia Medical Ltd
|
Revenue
|
441.1m
CNY
|
|
Cost of Revenue
|
-115.8m
CNY
|
|
Gross Profit
|
325.4m
CNY
|
|
Operating Expenses
|
-732.6m
CNY
|
|
Operating Income
|
-407.2m
CNY
|
|
Other Expenses
|
14.7m
CNY
|
|
Net Income
|
-392.5m
CNY
|
Free Cash Flow Analysis
Peijia Medical Ltd
Profitability Score
Profitability Due Diligence
Peijia Medical Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Peijia Medical Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Peijia Medical Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Peijia Medical Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Peijia Medical Ltd
According to Wall Street analysts, the average 1-year price target for Peijia Medical Ltd is 12.82 HKD with a low forecast of 9.49 HKD and a high forecast of 15.6 HKD.
Shareholder Return
Price
Peijia Medical Ltd
| Average Annual Return | -23.43% |
| Standard Deviation of Annual Returns | 30.74% |
| Max Drawdown | -90% |
| Market Capitalization | 2.5B HKD |
| Shares Outstanding | 675 331 421 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one Peijia Medical Ltd stock under the Base Case scenario is 4.07 HKD.
Compared to the current market price of 3.66 HKD, Peijia Medical Ltd is Undervalued by 10%.
You don't have any saved screeners yet
